Recro Pharma
-
Recro Pharma Reports Second Quarter Financials
Recro Pharma, Inc. of Malvern says the clinical stage specialty pharmaceutical company is on track to report top-line data from a Phase IIb clinical trial…
-
Recro Pharma Gains Russell Index Status
While some analysts thought Recro Pharma, Inc. of Malvern would face an uphill battle against pharmaceutical giants such as Johnson and Johnson, news continues to…
-
Recro Pharma Begins Clinical Trial Of Non-Opioid Dex-IN
Bunions hurt, and recovery from bunion surgery can take five months, but the Malvern specialty pharmaceutical company Recro Pharma announced they have just taken significant…
-
Recro Pharma Issues 1st Quarter Financials, Plans 2nd Quarter Clinical Trial
Recro Pharma, Inc., a Malvern-based specialty pharmaceutical company developing non-opioid therapeutics for the treatment of pain, recently reported financial results for the first quarter ended…
-
Local Business Leaders Nominated For Ernst & Young 2014 Entrepreneur Award
Ernst & Young selected five Chester County business leaders as finalists for the EY Entrepreneur of the Year awards for 2014 in the greater Philadelphia…

















































